OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report</p>
Yun Shu, Hui Li, Hongjuan Shang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 10387-10391
Open Access | Times Cited: 7
Yun Shu, Hui Li, Hongjuan Shang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 10387-10391
Open Access | Times Cited: 7
Showing 7 citing articles:
ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
S. Gendarme, O. Bylicki, C. Chouaïd, et al.
Current Oncology (2022) Vol. 29, Iss. 2, pp. 641-658
Open Access | Times Cited: 77
S. Gendarme, O. Bylicki, C. Chouaïd, et al.
Current Oncology (2022) Vol. 29, Iss. 2, pp. 641-658
Open Access | Times Cited: 77
Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers
Peiyi Xia, Lan Zhang, Pan Li, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Peiyi Xia, Lan Zhang, Pan Li, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Case Report: Response to crizotinib treatment in a patient with advanced non-small cell lung cancer with LDLR-ROS1 fusion
Yun Shu, Zhouyu Wang, Hongjuan Shang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Yun Shu, Zhouyu Wang, Hongjuan Shang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Fusion Genes Landscape of Lung Cancer Patients From Inner Mongolia, China
Lan Yu, Jinyang Liu, Jianchao Jia, et al.
Genes Chromosomes and Cancer (2024) Vol. 63, Iss. 7
Closed Access
Lan Yu, Jinyang Liu, Jianchao Jia, et al.
Genes Chromosomes and Cancer (2024) Vol. 63, Iss. 7
Closed Access
Gene Cluster Expression Index (GCEI) and Potential Indications for Targeted Therapy and Immunotherapy
A.K.S. Bhujanga Rao
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A.K.S. Bhujanga Rao
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report
YunYu Lin, Yan Lei, Linwei Li, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 831-836
Open Access
YunYu Lin, Yan Lei, Linwei Li, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 831-836
Open Access
Non-smoking woman with adenocarcinoma of the lung, IV stage with ROS1 mutation and acquired thrombophilia
Taivans Immanuels, Senterjakova Natalja, Viktors Kozirovskis, et al.
Journal of Pulmonology and Respiratory Research (2021) Vol. 5, Iss. 1, pp. 064-072
Open Access
Taivans Immanuels, Senterjakova Natalja, Viktors Kozirovskis, et al.
Journal of Pulmonology and Respiratory Research (2021) Vol. 5, Iss. 1, pp. 064-072
Open Access
